Marathon…A world class gold deposit
If you want the bullet on Marathon Gold (T.MOZ) spend three minutes watching this video from JustMiningStocks:
Year: 2019
FSD Pharma Announces Share Exchange Transaction with Aura Health
– Intended Transaction positions FSD to establish distribution channel in Germany & Eurozone –
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that it has entered into a share exchange transaction with Aura Health Inc. (“Aura”). Pursuant to the agreement, FSD acquired 13,562,386 Aura shares valued at $3 million issued from treasury in exchange for 13,181,019 FSD shares issued from treasury valued at $3 million. Aura Health is a Toronto-based cannabis company building an international network of vertically integrated businesses in the medical cannabis industry.
Goldplay: Developing the District
Goldplay’s (V.GPLY) San Marcial project consists of 1,250 hectares, located south of the La Rastra and Plomosas historical mines in one of most important multi-million ounces (Au-Ag) mine district in Sinaloa – Mexico. It is a large concession and Marcio Fonseca, the company’s President and CEO, together with Goldplay’s team based in the regions are driving the exploration program towards discoveries of large Au-Ag deposits.
Excellent Article on White Gold
Our friends at the Northern Miner have a great backgrounder article on White Gold. In it White Gold CEO David D’onofrio is quoted as saying,
FSD Pharma to Acquire Prismic Pharmaceuticals
This transaction positions FSD to help contribute to addressing the opioid crisis through use of synthetic cannabinoidsFSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company, announced today that they have entered into a securities exchange agreement dated April 22, 2019 (the “Agreement”) pursuant to which FSD Pharma has agreed to acquire all of the outstanding securities of Prismic (the “Transaction”). Prismic is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide’s (“PEA”) “entourage” effect on certain drugs impacting the endocannabinoid system.
World-Class Extractions: Adding Real Value to Cannabis
Anthony Durkacz has a unique perspective on Canada’s emerging cannabis industry. Through his First Republic Capital, he has financed FSD Pharma (C.HUGE), Canntab Therapeutics (C.PILL), Cannara Biotech (C.LOVE) and, now, World-Class Extractions (C.PUMP). In each case Durkacz has been looking for business models which go well beyond the simple cultivation of cannabis.
FSD Pharma gets Medical Sales Licence
I have an article up about FSD Pharma (C.HUGE) getting its medical sales licence up at Seeking Alpha.
Bayhorse Silver Q&A
- What is the relationship between Mineral Solutions and Bayhorse Silver?
Currently, we operate under a letter agreement that establishes a working relationship. This gives us the ability to do longer-term planning for the concentrate we produce. We work very closely with Mineral Solutions and provide them with the material they need to optimize and expand their process. Very much a win/win
FSD Pharma Receives Cannabis Sales License from Health Canada
New license positions FSD to serve the growing medicinal use marketsFSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license went into effect on April 18, 2019.
World Class Retains Mackie Research Capital for Capital Markets Services
World Class Extractions Inc. (CSE: PUMP) (“World Class” or the “Company“) is pleased to announce that it has retained the services of Mackie Research Capital Corporation (“Mackie Research“) to act as financial advisor to the Company.